Table 2 |
||||||
|
Univariate and multivariate Cox regression analysis |
||||||
|
Univariate |
Multivariate |
|||||
|
|
|
|||||
|
Variables |
HR |
95% CI |
p value |
HR |
95% CI |
P value |
|
|
||||||
|
Age (years) |
1.528 |
0.694 to 3.364 |
0.288 |
|||
|
Gender (m/f) |
1.007 |
0.983 to 1.031 |
0.577 |
|||
|
Sepsis (yes/no) |
2.688 |
0.918 to 7.874 |
0.072 |
1.004 |
0.154 to 6.553 |
0.997 |
|
MAP (mmHg) |
0.981 |
0.954 to 1.009 |
0.186 |
|||
|
Heart rate (bpm) |
0.995 |
0.976 to 1.014 |
0.583 |
|||
|
Noradrenaline (μg/kg/min) |
1.433 |
0.695 to 2.954 |
0.330 |
|||
|
FiO2 (%) |
1.002 |
0.980 to 1.025 |
0.873 |
|||
|
PaO2/FiO2 |
1.001 |
0.997 to 1.005 |
0.737 |
|||
|
CRP (mg/L) |
0.998 |
0.995 to 1.002 |
0.364 |
|||
|
Lactate (mmol/L) |
1.105 |
1.029 to 1.185 |
0.006* |
1.064 |
0.986 to 1.148 |
0.111 |
|
APACHE II score |
1.060 |
1.012 to 1.110 |
0.013* |
1.040 |
0.985 to 1.099 |
0.154 |
|
SOFA score |
1.107 |
1.006 to 1.219 |
0.038* |
1.073 |
0.971 to 1.185 |
0.167 |
|
VEGF (pg/ml) |
1.000 |
0.997 to 1.004 |
0.962 |
|||
|
Ang-1 (ng/ml) |
1.010 |
0.918 to 1.111 |
0.840 |
|||
|
Ang-2 (ng/ml)a |
1.034 |
1.013 to 1.056 |
0.001* |
1.033 |
1.012 to 1.055 |
0.002* |
|
Ang-2 (log10)a |
4.383 |
1.628 to 11.802 |
0.003* |
4.284 |
1.627 to 11.281 |
0.003* |
|
Ang-2/Ang-1 (log10)a |
2.630 |
1.207 to 5.729 |
0.015* |
2.384 |
1.061 to 5.360 |
0.036* b |
|
|
||||||
|
*p < 0.05. a tested separately from each other; b In this model APACHE II remained significant in the multivariate model (p = 0.039). Ang = Angiopoietin; APACHE II = Acute Physiology and Chronic Health Evaluation II; CI = confidence interval; CRP = C-reactive protein; f = female; FiO2 = fraction of inspired oxygen; HR = heart rate; m = male; MAP = mean arterial pressure; PaO2 = partial pressure of oxygen in arterial blood; SOFA = Sequential Organ Failure Assessment; VEGF = vascular endothelial growth factor. |
||||||
|
Kümpers et al. Critical Care 2008 12:R147 doi:10.1186/cc7130 |
||||||